Insulin resistance develops when your cells stop responding normally to insulin, forcing your pancreas to produce more and more of it to keep blood sugar in check. The causes range from excess body fat and chronic inflammation to sleep loss, genetics, and certain medications. In most cases, several of these factors overlap and reinforce each other.
How Cells Stop Responding to Insulin
Insulin works by docking onto a receptor on the surface of your cells, which triggers a chain of internal signals that ultimately opens the door for glucose to enter. The key player in this chain is a molecule called IRS-1, which acts like a relay switch. When everything works properly, IRS-1 passes the insulin signal forward, and glucose transporters move to the cell surface to pull sugar out of your blood.
In insulin resistance, that relay switch gets jammed. Certain stress signals inside the cell add chemical tags to IRS-1 in the wrong places, which prevents it from connecting to the insulin receptor at all. Once IRS-1 is tagged this way, the cell also marks it for destruction, breaking it down so there’s less of it available. The net result: insulin arrives at the cell, but the message never gets through. Your pancreas compensates by releasing even more insulin, which works for a while but eventually can’t keep up.
Excess Fat Inside Cells
The connection between body fat and insulin resistance isn’t just about how much fat you carry. It’s about where that fat ends up at the cellular level. When fat intake consistently exceeds what your cells can burn or safely store, fatty byproducts accumulate inside muscle and liver cells. Two of these byproducts are especially damaging.
The first, diacylglycerol, activates enzymes that directly interfere with the insulin signaling relay described above. The second, ceramides, block the activation of a critical downstream enzyme that insulin depends on to do its job. Ceramides accomplish this through multiple routes: they activate competing enzymes that physically prevent insulin’s signal from reaching its target, and they stimulate a “off switch” enzyme that deactivates the pathway further. This is why two people at the same body weight can have very different levels of insulin resistance. What matters is how much fat has infiltrated the cells that need to respond to insulin.
Inflammation From Fat Tissue
Fat tissue isn’t just storage. It’s an active organ that releases signaling molecules, and when it becomes overloaded, those signals shift toward inflammation. As fat cells expand, they increase production of reactive oxygen species (a form of cellular stress), which in turn boosts the release of inflammatory molecules like TNF-alpha and IL-6 while suppressing adiponectin, a hormone that normally promotes insulin sensitivity.
These inflammatory signals activate two stress pathways inside cells, called JNK and NF-kB, that directly interfere with insulin signaling. This is the same mechanism that anti-inflammatory drugs like high-dose aspirin were found to improve blood sugar control, a discovery that helped researchers understand that insulin resistance is, in part, an inflammatory condition. Saturated fatty acids make this worse by binding to the same immune receptors that normally detect bacterial infections, essentially tricking the body into mounting an inflammatory response against its own fat.
What You Eat Matters Beyond Calories
Diet contributes to insulin resistance through specific metabolic pathways, not just excess calories. Fructose is a clear example. Unlike glucose, which is used by every cell in your body, fructose is processed almost entirely by the liver. There, it activates the genetic machinery for converting sugar into fat far more effectively than glucose does.
In a controlled trial, people who drank beverages sweetened with fructose or sucrose (table sugar) for several weeks showed a twofold increase in the rate at which their livers produced new fat compared to a control group. This liver fat accumulation reduces the liver’s ability to respond to insulin, a condition called hepatic insulin resistance, and it happens independently of whether someone gains weight. The practical implication: sugary drinks and foods high in added sugars can worsen insulin resistance even before they show up on the scale.
Mitochondrial Stress
Your mitochondria, the energy-producing structures inside cells, play a surprisingly specific role. Research using a tool that generates oxidative stress exclusively inside mitochondria (without damaging their ability to produce energy) found that this stress alone was enough to impair the movement of glucose transporters to the cell surface in both fat and muscle cells. Notably, the early steps of insulin signaling remained intact. The problem wasn’t that insulin’s message didn’t get through; it was that the final step, actually opening the door for glucose, failed.
This finding helps explain why people with normal-looking insulin blood tests can still have trouble clearing sugar from their blood. It also highlights why antioxidant-rich diets and regular exercise, both of which improve mitochondrial health, tend to improve insulin sensitivity even when weight doesn’t change.
Sleep Deprivation
Poor sleep is one of the fastest-acting causes of insulin resistance, and the effect is larger than most people expect. Restricting sleep to four or five hours per night for just four to five nights reduces insulin sensitivity by 21 to 29 percent, depending on the study. Even a single night of total sleep deprivation has been shown to cut insulin sensitivity by about 21 percent with no compensatory increase in insulin production.
The damage is dose-dependent. Cutting sleep to four hours produces greater reductions than cutting to five, and the effect hits peripheral tissues like muscle hardest, with one study documenting a 29 percent drop in peripheral insulin sensitivity after five nights of four-hour sleep. REM sleep appears to be particularly important; when sleep restriction disproportionately cuts into REM stages, insulin sensitivity drops by about 16 percent regardless of total sleep time. For anyone working on metabolic health, sleep is not optional.
Genetics and Family History
Nearly 60 regions of the human genome have been linked to insulin resistance through large-scale genetic studies. Among the most consistently replicated are variants affecting IRS1 (the same relay molecule that gets jammed in the cellular mechanism), GRB14, PPARG, and several others involved in how fat cells develop and function. For four of the top candidate genes, carrying the risk version reduces the gene’s activity in fat tissue and skeletal muscle. For one gene, GRB14, the risk version actually increases its expression, which is notable because GRB14 acts as a natural brake on insulin signaling.
These genetic variants don’t guarantee insulin resistance. They shift your baseline, meaning you may develop problems at a lower level of body fat or dietary stress than someone without those variants. This partly explains why insulin resistance runs in families and why some lean individuals develop type 2 diabetes.
Medications That Trigger Insulin Resistance
Glucocorticoids (steroids like prednisone, dexamethasone, and hydrocortisone) are the most common medication-related cause. They attack insulin sensitivity from multiple angles simultaneously. In muscle, they reduce production of IRS-1 while ramping up proteins that actively oppose insulin signaling. In the liver, they decrease the responsiveness of insulin receptors and boost the production of new glucose, raising blood sugar directly. They also promote the breakdown of muscle protein and the release of fatty acids from fat stores, both of which feed the lipid accumulation cycle described earlier.
On top of all this, glucocorticoids suppress adiponectin, the protective hormone from fat tissue that normally enhances insulin sensitivity. They even affect bone: by reducing levels of osteocalcin, a hormone released by bone-building cells, they remove yet another signal that supports healthy insulin response. This is why people on long-term steroid therapy frequently develop significant blood sugar problems, and why some progress to full diabetes during treatment.
How Insulin Resistance Is Measured
The most common clinical tool is the HOMA-IR score, calculated from a single fasting blood draw that measures both glucose and insulin. A healthy reference range for HOMA-IR falls between roughly 0.56 and 3.50, though the exact cutoffs vary by population and lab. Scores consistently above the upper end suggest your body is producing more insulin than normal to maintain blood sugar, which is the hallmark of insulin resistance.
HOMA-IR is useful for tracking trends over time, but it’s a snapshot of fasting conditions and won’t catch problems that only show up after meals. If your doctor suspects insulin resistance but your fasting numbers look borderline, they may use a glucose tolerance test or check your fasting insulin level directly. The earlier insulin resistance is identified, the more reversible it tends to be, particularly through the lifestyle factors (sleep, diet, exercise, and body composition) that drive most cases.